Objective. Evaluation of the neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis
and steatosis in HBV patients qualified for antiviral treatment.
Materials and method. The study comprised 38 CHB patients who had commenced antiviral treatment, and 20 healthy
volunteers who constituted the clinical control group. All patients had their blood count taken and underwent hepatic
assessment using transient elastography with CAP (controlled attenuation parameter).
Results. It was found that the mean hepatic fibrosis was 8.7 kPa (±8.8) and the mean liver steatosis – 286 db/m (±64). Mean
NLR – 2.78(±1.1), whereas in the control group the mean NLR value was 1.64(±0.98). A negative linear correlation (r= -0.34;
p=0.035) was found between liver fibrosis and the NLR value in the study group. No correlation was observed between
hepatic steatosis and the NLR. Mean MPV – 12.6fl (±3.1), which was considerably higher in the CBH patients than in the
control group. A positive correlation (r= 0.79, p= 0.001) was found between MPV and disease severity evaluated with transient
elastography.
Conclusions. The NLR and the MPV were significantly higher in the CHB patients than in the healthy volunteers. Both the
NLR and the MPV can be treated as predictive factors for liver fibrosis in this group of patients.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
Informacja
SZANOWNI CZYTELNICY!
UPRZEJMIE INFORMUJEMY, ŻE BIBLIOTEKA FUNKCJONUJE W NASTĘPUJĄCYCH GODZINACH:
Wypożyczalnia i Czytelnia Główna: poniedziałek – piątek od 9.00 do 19.00